Malaria is one of the most devastating infectious diseases of humans. It is problematic
clinically and economically as it prevails in poorer countries and regions, strongly hindering …

Primaquine is the only antimalarial drug available to clinicians for the treatment of relapsing
forms of malaria. Primaquine development and usage dates back to the 1940s and has …

Plasmodium vivax is the most widespread human malaria parasite, in part because it can
form latent liver stages known as hypnozoites after transmission by female anopheline …

Drugs targeting multiple stages of the Plasmodium vivax life cycle are needed to reduce the
health and economic burdens caused by malaria worldwide. N-myristoyltransferase (NMT) …

Background Despite increased efforts to control and ultimately eradicate human malaria,
Plasmodium ovale malaria is for the most part outside the focus of research or public health …

We retrospectively analyzed epidemiologic, clinical, and biologic characteristics of 368
Plasmodium ovale wallikeri and 309 P. ovale curtisi infections treated in France during …

Plasmodium vivax malaria is characterized by repeated episodes of blood stage infection
(relapses) resulting from activation of dormant stages in the liver, so-called hypnozoites …

Abstract According to WHO World Malaria Report (2018), nearly 219 million new cases of
malaria occurred and a total no. of 435 000 people died in 2017 due to this infectious …

Background Plasmodium ovale curtisi and wallikeri are perceived as relapsing malarial
parasites. Contrary to Plasmodium vivax, direct evidence for this hypothesis is scarce. The …

Background Malaria is a major public health problem, particularly in the tropical regions of
America, Africa and Asia. Plasmodium falciparum is not only the most widespread but also …